Virginie Gillet1, Annie Ouellet2, Yulia Stepanov2, Rodosthenis S Rodosthenous3, Erika Kathe Croft1, Kasey Brennan3, Nadia Abdelouahab2, Andrea Baccarelli3, Larissa Takser1,4. 1. Département de Pédiatrie, Faculté de Médecine et des Sciences de la Santé, Université de Sherbrooke, Sherbrooke, Québec, Canada. 2. Département d'Obstétrique et de Gynécologie, Faculté de Médecine et des Sciences de la Santé, Université de Sherbrooke, Sherbrooke, Québec, Canada. 3. Department of Environmental Health, Harvard T.H. Chan School of Public Health, Boston, Massachusetts. 4. Département de Psychiatrie, Faculté de Médecine et des Sciences de la Santé, Université de Sherbrooke, Sherbrooke, Québec, Canada.
Abstract
CONTEXT: Underlying mechanisms leading to gestational diabetes mellitus (GDM) are still under investigation, and it is unclear whether the placenta plays a role in triggering glucose intolerance or if its functions are modified in response to the hyperglycemia. Circulating miRNAs are involved in placental development and function and are encapsulated in extracellular vesicles (EVs). OBJECTIVE: To compare differential expression of miRNAs in circulating EVs in pregnancies complicated by GDM vs controls. METHODS: This was a case-control study nested in a prospective pregnancy cohort including 23 women with GDM and 46 matched controls. The presence of serum EVs in early pregnancy was validated by transmission electron microscopy. Placental dimensions were assessed at 11 to 13 weeks of gestation. Differential expression of 17 miRNAs encapsulated in EVs (miR‒122-5p, miR‒132-3p, miR-1323, miR‒182-3p, miR‒210-3p, miR‒29a-3p, miR‒29b-3p, miR‒342-3p, miR‒517-5p, miR‒517a-3p, miR‒518b, miR-520h, miR‒525-5p, miR‒136-5p, miR‒342-3p, miR‒376c-5p, and miR‒494-3p) was assessed using quantitative reverse transcription PCR. RESULTS: EVs were present in the early phase of placentation (6 to 15 weeks of gestation) in both cases and controls. No differences were observed for placental dimensions and estimated placental volume between GDM and control groups. Ten miRNAs (miR‒122-5p; miR‒132-3p; miR‒1323; miR‒136-5p; miR‒182-3p; miR‒210-3p; miR‒29a-3p; miR‒29b-3p; miR‒342-3p, and miR-520h) showed significantly higher levels in GDM cases than in controls (P ≤ 0.05). Bioinformatics analysis showed that these miRNAs are involved in trophoblast proliferation/differentiation as well as in insulin secretion/regulation and glucose transport in pregnant women. CONCLUSION: The miRNA content of blood EVs may be a promising avenue for studying the early effect of impaired glucose metabolism on placental development.
CONTEXT: Underlying mechanisms leading to gestational diabetes mellitus (GDM) are still under investigation, and it is unclear whether the placenta plays a role in triggering glucose intolerance or if its functions are modified in response to the hyperglycemia. Circulating miRNAs are involved in placental development and function and are encapsulated in extracellular vesicles (EVs). OBJECTIVE: To compare differential expression of miRNAs in circulating EVs in pregnancies complicated by GDM vs controls. METHODS: This was a case-control study nested in a prospective pregnancy cohort including 23 women with GDM and 46 matched controls. The presence of serum EVs in early pregnancy was validated by transmission electron microscopy. Placental dimensions were assessed at 11 to 13 weeks of gestation. Differential expression of 17 miRNAs encapsulated in EVs (miR‒122-5p, miR‒132-3p, miR-1323, miR‒182-3p, miR‒210-3p, miR‒29a-3p, miR‒29b-3p, miR‒342-3p, miR‒517-5p, miR‒517a-3p, miR‒518b, miR-520h, miR‒525-5p, miR‒136-5p, miR‒342-3p, miR‒376c-5p, and miR‒494-3p) was assessed using quantitative reverse transcription PCR. RESULTS: EVs were present in the early phase of placentation (6 to 15 weeks of gestation) in both cases and controls. No differences were observed for placental dimensions and estimated placental volume between GDM and control groups. Ten miRNAs (miR‒122-5p; miR‒132-3p; miR‒1323; miR‒136-5p; miR‒182-3p; miR‒210-3p; miR‒29a-3p; miR‒29b-3p; miR‒342-3p, and miR-520h) showed significantly higher levels in GDM cases than in controls (P ≤ 0.05). Bioinformatics analysis showed that these miRNAs are involved in trophoblast proliferation/differentiation as well as in insulin secretion/regulation and glucose transport in pregnant women. CONCLUSION: The miRNA content of blood EVs may be a promising avenue for studying the early effect of impaired glucose metabolism on placental development.
Authors: Carlos Salomon; Katherin Scholz-Romero; Suchismita Sarker; Emma Sweeney; Miharu Kobayashi; Paula Correa; Sherri Longo; Gregory Duncombe; Murray D Mitchell; Gregory E Rice; Sebastian E Illanes Journal: Diabetes Date: 2015-12-30 Impact factor: 9.461
Authors: Angela Jones; Kirsty M Danielson; Miles C Benton; Olivia Ziegler; Ravi Shah; Richard S Stubbs; Saumya Das; Donia Macartney-Coxson Journal: Obesity (Silver Spring) Date: 2017-08-21 Impact factor: 5.002
Authors: Caitlin G Howe; Helen B Foley; Elizabeth M Kennedy; Sandrah P Eckel; Thomas A Chavez; Dema Faham; Brendan H Grubbs; Laila Al-Marayati; Deborah Lerner; Shakira Suglia; Theresa M Bastain; Carmen J Marsit; Carrie V Breton Journal: Epigenetics Date: 2021-03-18 Impact factor: 4.528
Authors: Tania L Gonzalez; Laura E Eisman; Nikhil V Joshi; Amy E Flowers; Di Wu; Yizhou Wang; Chintda Santiskulvong; Jie Tang; Rae A Buttle; Erica Sauro; Ekaterina L Clark; Rosemarie DiPentino; Caroline A Jefferies; Jessica L Chan; Yayu Lin; Yazhen Zhu; Yalda Afshar; Hsian-Rong Tseng; Kent Taylor; John Williams; Margareta D Pisarska Journal: Epigenomics Date: 2021-05-25 Impact factor: 4.778
Authors: Lindsey N Block; Brittany D Bowman; Jenna Kropp Schmidt; Logan T Keding; Aleksandar K Stanic; Thaddeus G Golos Journal: Biol Reprod Date: 2021-01-04 Impact factor: 4.161
Authors: Amy E Flowers; Tania L Gonzalez; Nikhil V Joshi; Laura E Eisman; Ekaterina L Clark; Rae A Buttle; Erica Sauro; Rosemarie DiPentino; Yayu Lin; Di Wu; Yizhou Wang; Chintda Santiskulvong; Jie Tang; Bora Lee; Tianyanxin Sun; Jessica L Chan; Erica T Wang; Caroline Jefferies; Kate Lawrenson; Yazhen Zhu; Yalda Afshar; Hsian-Rong Tseng; John Williams; Margareta D Pisarska Journal: Biol Reprod Date: 2022-03-19 Impact factor: 4.161
Authors: Caitlin G Howe; Helen B Foley; Shohreh F Farzan; Thomas A Chavez; Mark Johnson; John D Meeker; Theresa M Bastain; Carmen J Marsit; Carrie V Breton Journal: Epigenetics Date: 2021-10-30 Impact factor: 4.861